|
 We licensed exclusive, worldwide rights to the technologies related to pegloticase from Duke University and Mountain View Pharmaceuticals, Inc., a California corporation. Duke University developed the recombinant uricase enzyme and Mountain View Pharmaceuticals, Inc. developed the PEGylation technology.
Duke University and Mountain View Pharmaceuticals, Inc. were granted U.S. and foreign patents covering the licensed technology. We depend on third parties to manufacture pegloticase and have entered into commercial supply agreements with third-party manufacturers.
Watson Pharma serves as the exclusive U.S. distributor of our authorized generic version of oxandrolone tablets, an Oxandrin® brand equivalent product that we supply to Watson Pharma.
|
